Please login to the form below

Not currently logged in
Email:
Password:

Icon appoints Hugh Brady to board

He is former president of University College Dublin
ICON Hugh Brady

The contract research organisation (CRO) ICON has appointed Dr Hugh Brady to its board of directors.

Dr Brady is former president of University College Dublin (UCD) in Ireland, where he served from 2004 to 2013.

During this time he oversaw the expansion of the University's science, engineering and biomedical research capacity, including the development of several new research centres.

He also built links across the world, establishing the Beijing-Dublin International College and the UCD Shenzhen Health Sciences Institute in China.

In his role at Icon Dr Brady will be able to offer an in-depth knowledge of academia and research networks to Icon's efforts to support the pharma, biotech and medical device industries.

Thomas Lynch, chairman of Icon said: “His inspirational leadership of UCD, Irelands' largest university, during the past ten years, extensive international experience, especially in Asia, coupled with a distinguished career as an academic clinician in Ireland and the US will bring invaluable experience and expertise to Icon.”

2nd May 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics